IDIBELL on the media
An investigation by HUB and IDIBELL shows the adaptation of bacteria in COPD patients and prolonged treatment with azithromycin
The IDIBELL Bacterial Epidemiology research group has published a paper on the adaptation of Haemophilus spp in patients with chronic obstructive pulmonary disease (COPD) and prolonged treatment with azithromycin.
Association between polyphenols from diet and body weight change
The results, published in Antioxidant and Obesity scientific journals, show that the intake of most polyphenols is associated with maintenance or a lower weight gain, highlighting those polyphenols present in fruits, vegetables, olive oil, tea, cocoa, or cereals integral.
Jut Against Cancer Association donates 6,000 euros to pancreatic cancer research
The Association Jut against cancer is a recently created association from Sant Boi de Llobregat that raises funds through different solidarity, sporting and creative initiatives in which the patients participate.
A drug that prevents DNA reparation could improve the survival of patients with one of the most aggressive prostate cancers
The results of the TRITON3 study show that patients with prostate cancer treated with a PARP inhibitor, called Rucaparib, take almost twice as long for the disease to progress than those treated with conventional chemotherapy.
The Govern awards the Josep Trueta plaque for health merit to the Hospital de Bellvitge
The Govern approved today the awarding of the Josep Trueta medals and plaques to outstanding professionals and entities in the health field. Among the award-winning entities is the Bellvitge University Hospital, for its work as a reference center of maximum complexity for 2 million people. Likewise, one of the individual medals has been for Dr. Mònica Povedano, a neurologist at Hospital de Bellvitge and IDIBELL researcher.
The diagnosis and treatment of glioblastoma during the 2008 financial crisis and the COVID-19 pandemic
The availability and ease of resources, and the time between the appearance of the primary tumor and the start of treatment are key to the patient’s prognosis, already poor in this disease.
An anti-diabetic and anti-inflammatory diet before the disease may contribute to a better prognosis in breast cancer survivors
A study led by researchers from the Nutrition and Cancer research group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) examined the relationship between dietary patterns before breast cancer diagnosis and the survival of these patients.
Great success of the 6th sLHam of women scientists
With the Barradas auditorium full, the 6th IDIBELL sLHam of female scientists was a total success. This year the sLHameres were Sandra Acosta, Begoña Arán, Lidia Franco, Núria Lloberas, Patricia Prada and Gemma Via, Fatima Akhtar and Paula Barrios, who, in a five-minute informative talk, explained their career in the scientific world, the challenges they have been overcoming and the motivations that have helped them to do so.
The discovery of an operable lesion in the brain makes it possible to control epileptic seizures triggered by eating act with surgery
A study led by the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB) has discovered an encephalocele in the right temporal pole of the brain in some of patients.
M Carolina Florian new ICREA Research Professor
Dra. M Carolina Florian, group leader at IDIBELL, has been appointed as an ICREA Research Professor. ICREA, the Catalan Institution for Research and Advanced Studies, offers permanent, tenured positions to the most talented and extraordinary scientists and academics to come and work in Catalonia. Over the years these positions have become a synonym for global academic excellence.